Literature DB >> 28727653

Rising Incidence of Paediatric Inflammatory Bowel Disease in Canterbury, New Zealand, 1996-2015.

Robert N Lopez1, Laura Appleton1, Richard B Gearry2, Andrew S Day1.   

Abstract

BACKGROUND: The incidence of paediatric inflammatory bowel disease (IBD) around the world is increasing. Canterbury, New Zealand, has one of the highest Crohn disease (CD) incidence rates published. The present study aimed to document the incidence of paediatric IBD in Canterbury between 1996 and 2015.
METHODS: All patients diagnosed with IBD in Canterbury, while younger than 16 years, between January 1, 1996 and December 31, 2015 were identified. Demographic and disease phenotypic details were collected and entered into a secure database. Age-specific population data for Canterbury were obtained and annual incidence rates were then calculated.
RESULTS: The mean annual incidence rate over the 20-year period was 7.18/100,000 (95% confidence interval 5.55-8.81) children. There was a 4-fold increase in the incidence of paediatric IBD in Canterbury between 1996 and 2015. The ratio of CD to ulcerative colitis (UC) diagnosed was 8.4:1. Disease phenotype of CD and UC, based on the Paris classification, were comparable with other studies.
CONCLUSIONS: The incidence of paediatric IBD in Canterbury has increased dramatically during the last 2 decades. Some of the observed incidence rates are among the highest documented anywhere in the world. The preponderance of CD over UC in the present study is the highest published.

Entities:  

Mesh:

Year:  2018        PMID: 28727653     DOI: 10.1097/MPG.0000000000001688

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  9 in total

1.  Impact of a Camp upon Disease-Specific Knowledge and Quality of Life in Children and Adolescents with Inflammatory Bowel Disease.

Authors:  Robert N Lopez; Andrew McCombie; Richard B Gearry; Andrew S Day
Journal:  Inflamm Intest Dis       Date:  2020-02-26

2.  Three-year outcomes of childhood inflammatory bowel disease in New Zealand: A population-based cohort study.

Authors:  Natalie G Martin; Amin J Roberts; Helen M Evans; Jonathan Bishop; Andrew S Day
Journal:  JGH Open       Date:  2020-02-07

3.  Transition clinics: an observational study of themes important to young people with inflammatory bowel disease.

Authors:  Shwan Karim; Jody A Porter; Andrew McCombie; Richard B Gearry; Andrew S Day
Journal:  Transl Pediatr       Date:  2019-01

4.  Single high-dose oral vitamin D3 treatment in New Zealand children with inflammatory bowel disease.

Authors:  Natalie G Martin; Tarah Rigterink; Mustafa Adamji; Catherine L Wall; Andrew S Day
Journal:  Transl Pediatr       Date:  2019-01

5.  Validation of a Revised Knowledge Assessment Tool for Children with Inflammatory Bowel Disease (IBD-KID2).

Authors:  Angharad Vernon-Roberts; Anthony Otley; Chris Frampton; Richard B Gearry; Andrew S Day
Journal:  Inflamm Intest Dis       Date:  2020-02-21

6.  Diagnostic Delay in Paediatric Inflammatory Bowel Disease-A Systematic Investigation.

Authors:  Bahareh Sophia Khalilipour; Andrew S Day; Kristin Kenrick; Michael Schultz; Kristina Aluzaite
Journal:  J Clin Med       Date:  2022-07-18       Impact factor: 4.964

Review 7.  Current global trends in the incidence of pediatric-onset inflammatory bowel disease.

Authors:  Josef Sýkora; Renáta Pomahačová; Marcela Kreslová; Dominika Cvalínová; Přemysl Štych; Jan Schwarz
Journal:  World J Gastroenterol       Date:  2018-07-07       Impact factor: 5.742

8.  Immunomodulatory effect of Syphacia obvelata in treatment of experimental DSS-induced colitis in mouse model.

Authors:  Niloofar Taghipour; Nariman Mosaffa; Hamid Asadzadeh Aghdaei; Mohammad Rostami-Nejad; Joel V Weinstock; Sarira Shahnavaz; Mohammad Reza Zali
Journal:  Sci Rep       Date:  2019-12-13       Impact factor: 4.379

Review 9.  Exploitation of Marine-Derived Robust Biological Molecules to Manage Inflammatory Bowel Disease.

Authors:  Muhammad Bilal; Leonardo Vieira Nunes; Marco Thúlio Saviatto Duarte; Luiz Fernando Romanholo Ferreira; Renato Nery Soriano; Hafiz M N Iqbal
Journal:  Mar Drugs       Date:  2021-03-30       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.